Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells.
Ludvigsen
Eva
E
Department of Medical Sciences, University Hospital, 751 85 Uppsala, Sweden.
Stridsberg
Mats
M
Taylor
John E
JE
Culler
Michael D
MD
Oberg
Kjell
K
Janson
Eva T
ET
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology; D045744:Cell Line, Tumor / Q000187:drug effects / Q000201:enzymology; D002766:Cholecystokinin / Q000494:pharmacology; D053379:Chromogranin A; D002864:Chromogranins / Q000378:metabolism; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004789:Enzyme Activation; D006801:Humans; D008934:Mitogens / Q000494:pharmacology; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000378:metabolism*; D015282:Octreotide / Q000494:pharmacology; D011494:Protein Kinases / Q000187:drug effects / Q000378:metabolism; D017481:Receptors, Somatostatin / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology*
D018931:Antineoplastic Agents, Hormonal; D053379:Chromogranin A; D002864:Chromogranins; D008934:Mitogens; D017481:Receptors, Somatostatin; C101130:somatostatin receptor type 1; D005576:Colforsin; D013004:Somatostatin; C094573:somatostatin receptor 5; D002766:Cholecystokinin; C093733:somatostatin receptor 2; D000242:Cyclic AMP; D011494:Protein Kinases; D015282:Octreotide